Share on:
Citoxlab acquired AccelLAB, a Canadian clinical research organization specialized in the pre-clinical assessment of new medical devices. The move complements Citoxlab’s core business that focuses on drug development.
AccelLAB was founded in 2004 with a focus on development of new cardiac stents, valves, pacemakers, etc. Its services were recently enlarged to other specialties such as orthopaedics, Ear, Nose and Throat and dermatology.
AccelLAB is staffed by ~100 employees, and its facilities include operating rooms, laboratories, a medical imaging department (scanning and MRI) and clinical pathology and histopathology laboratories. Following this acquisition, Dr. Guy Leclerc remains the Managing Director of AccelLAB.
Source: CiToxLAB
RELATED ARTICLES
Janco Medical to Focus on Packaging and Cleanroom Manufacturing
Apr 10 2024 , Julie A. Vetalice
Evonik Grows Capacity for Customized RESOMER Powder Biomaterials
Apr 10 2024 , Julie A. Vetalice
Exploring Why Automation Leads to Improved Medical Device Manufacturing
Apr 09 2024 , Lowell
FDA De Novo for Orthobond’s Ostaguard Antibacterial Surface Treatment
Apr 08 2024 , Julie A. Vetalice